159 related articles for article (PubMed ID: 36351577)
1. Reversible Brain Atrophy in Cryptogenic New-onset Refractory Status Epilepticus.
Watanabe T; Nakamori M; Ishikawa K; Motoda A; Neshige S; Yamamoto S; Katahira K; Higaki T; Ueno H; Iizuka T; Maruyama H
Intern Med; 2023 Jun; 62(12):1835-1842. PubMed ID: 36351577
[TBL] [Abstract][Full Text] [Related]
2. The timelines of MRI findings related to outcomes in adult patients with new-onset refractory status epilepticus.
Kim HJ; Lee SA; Kim HW; Kim SJ; Jeon SB; Koo YS
Epilepsia; 2020 Aug; 61(8):1735-1748. PubMed ID: 32715470
[TBL] [Abstract][Full Text] [Related]
3. [A case of cryptogenic new-onset refractory status epilepticus (NORSE) in which cerebrospinal fluid IL-6 was elevated with increased seizure frequency early in the disease: a case report].
Nakada R; Terasawa Y; Sato T; Takatsu H; Kaito N; Iguchi Y
Rinsho Shinkeigaku; 2023 Dec; 63(12):843-846. PubMed ID: 37989289
[TBL] [Abstract][Full Text] [Related]
4. Blood-brain barrier damage and new onset refractory status epilepticus: An exploratory study using dynamic contrast-enhanced magnetic resonance imaging.
Li H; Liu X; Wang R; Lu A; Ma Z; Wu S; Lu H; Du Y; Deng K; Wang L; Yuan F
Epilepsia; 2023 Jun; 64(6):1594-1604. PubMed ID: 36892496
[TBL] [Abstract][Full Text] [Related]
5. Cryptogenic new-onset refractory status epilepticus (NORSE) following blood transfusion in a patient with severe anemia.
Wu CK; Culbertson CJ; Von Stein EL; Walia S; Krishnamohan P; Threlkeld ZD
Epileptic Disord; 2021 Apr; 23(2):403-406. PubMed ID: 33881399
[TBL] [Abstract][Full Text] [Related]
6. Severe, Refractory Seizures: New-Onset Refractory Status Epilepticus and Febrile Infection-Related Epilepsy Syndrome.
Carson R; Stredny CM
Med Clin North Am; 2024 Jan; 108(1):201-213. PubMed ID: 37951651
[TBL] [Abstract][Full Text] [Related]
7.
Nardetto L; Zoccarato M; Santelli L; Tiberio I; Cecchin D; Giometto B
J Neurol Sci; 2017 Oct; 381():100-102. PubMed ID: 28991656
[No Abstract] [Full Text] [Related]
8. New onset refractory status epilepticus (NORSE).
Sculier C; Gaspard N
Seizure; 2019 May; 68():72-78. PubMed ID: 30482654
[TBL] [Abstract][Full Text] [Related]
9. Cryptogenic New Onset Refractory Status Epilepticus (NORSE) in adults-Infectious or not?
Costello DJ; Kilbride RD; Cole AJ
J Neurol Sci; 2009 Feb; 277(1-2):26-31. PubMed ID: 19013586
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of subsequent extra-temporal involvement in cryptogenic new onset refractory status epilepticus (NORSE) initially diagnosed with limbic encephalitis.
Choi JY; Kim EJ; Moon SY; Kim TJ; Huh K
Epilepsy Res; 2019 Dec; 158():106215. PubMed ID: 31669912
[TBL] [Abstract][Full Text] [Related]
11. New-onset refractory status epilepticus in an adult with an atypical presentation of cat-scratch disease: successful treatment with high-dose corticosteroids.
Laswell EM; Chambers KD; Whitsel DR; Poudel K
Pharmacotherapy; 2015 Jun; 35(6):e106-10. PubMed ID: 26044784
[TBL] [Abstract][Full Text] [Related]
12. New-onset Refractory Status Epilepticus Involving the Limbic System, Spinal Cord, and Peripheral Nerves.
Daida K; Nishioka K; Takanashi M; Kobayashi M; Yoshikawa K; Kusunoki S; Yokoyama K; Hattori N
Intern Med; 2020 Jan; 59(2):267-270. PubMed ID: 31511489
[TBL] [Abstract][Full Text] [Related]
13. Cryptogenic new-onset refractory status epilepticus responded to anti-interleukin-6 treatment.
Wadayama T; Shimizu M; Yata T; Ishikura T; Kajiyama Y; Hirozawa D; Okuno T; Mochizuki H
J Neuroimmunol; 2022 Feb; 363():577789. PubMed ID: 34973472
[TBL] [Abstract][Full Text] [Related]
14. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort).
Sculier C; Barcia Aguilar C; Gaspard N; Gaínza-Lein M; Sánchez Fernández I; Amengual-Gual M; Anderson A; Arya R; Burrows BT; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Gorman M; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello J; Rusie A; Sperberg K; Stredny CM; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
Epilepsia; 2021 Jul; 62(7):1629-1642. PubMed ID: 34091885
[TBL] [Abstract][Full Text] [Related]
15. Early clinical features of new-onset refractory status epilepticus (NORSE) in adults.
Haanpää A; Laakso SM; Kinnunen A; Kämppi L; Forss N
BMC Neurol; 2022 Dec; 22(1):495. PubMed ID: 36539824
[TBL] [Abstract][Full Text] [Related]
16. A case of new onset refractory status epilepticus in a U.S. traveler with Japanese encephalitis.
Osbourn SR; Ryan KE; Cannard KR; Ma Y
J Neuroimmunol; 2023 Oct; 383():578193. PubMed ID: 37659268
[TBL] [Abstract][Full Text] [Related]
17. Prolonged treatment of refractory status epilepticus in a child.
Sahin M; Riviello JJ
J Child Neurol; 2001 Feb; 16(2):147-50. PubMed ID: 11292225
[TBL] [Abstract][Full Text] [Related]
18. Five cases of new onset refractory status epilepticus (NORSE) syndrome: outcomes with early immunotherapy.
Gall CR; Jumma O; Mohanraj R
Seizure; 2013 Apr; 22(3):217-20. PubMed ID: 23333762
[TBL] [Abstract][Full Text] [Related]
19. A retrospective cohort study of new-onset refractory status epilepticus (NORSE): clinical features, timing of immunotherapy and outcomes.
Werbaneth K; Mausolf M; Seliger J; Le S
Epileptic Disord; 2022 Oct; 24(5):867-876. PubMed ID: 35892128
[TBL] [Abstract][Full Text] [Related]
20. Time to FIRE NORSE: A single acronym for a heterogeneous presentation. Further information from a case series and discussion of the literature.
Alaskar AM; Aljohani MA; Dionisio S; Asiry MA; Alqadi K
J Neuroimmunol; 2024 Mar; 388():578298. PubMed ID: 38330780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
